GIA announces the release of a comprehensive global report on Acute Myeloid Leukemia (AML) Therapeutics markets. The global market for Acute Myeloid Leukemia (AML) Therapeutics is projected to reach US$243 million by the year 2017, primarily driven by the rising incidence level, growing aging population, high level of unmet needs, increased relapse rates, and strong drug pipeline. Growth in the ...
